The Inside Sales Representative – Preclinical & Standalone Biomarkers is responsible for managing the full sales cycle for biomarker-driven opportunities, with a primary focus on preclinical and standalone biomarker services.
This role serves as both the initial scientific and commercial point of contact and the primary owner of opportunities through to close. The Inside Sales Representative will drive revenue by engaging inbound and outbound leads, conducting scientific discovery, developing proposals in collaboration with internal teams, and closing business within defined account segments.
This position is designed to support faster-cycle, high-volume biomarker opportunities, enabling rapid response, improved conversion rates, and efficient revenue generation.
Respond to inbound biomarker inquiries with a strong emphasis on same-day engagement
Conduct discovery calls to assess:
Study objectives
Sample type (tumor tissue, blood, FFPE, etc.)
Biomarker modality (IHC, flow cytometry, genomics, proteomics)
Timeline, urgency, and budget awareness
Position appropriate preclinical and standalone biomarker solutions
Own qualified opportunities from initial engagement through close
Develop and execute sales strategy for each opportunity
Collaborate with scientific and operations teams to:
Scope studies
Build proposals and pricing
Present solutions and proposals to clients
Negotiate and close deals within defined authority levels
Maintain consistent follow-up to drive opportunities to conversion
Identify and engage prospective clients across biotech and emerging pharma segments
Target key stakeholders including:
Translational scientists
Preclinical researchers
Biomarker leads
Leverage conferences (AACR, SITC), publications, and data platforms to identify opportunities
Execute targeted outbound campaigns focused on preclinical and biomarker-driven research
Create and manage opportunities within Salesforce (SFDC)
Maintain accurate pipeline visibility including:
Probability
Forecasted revenue
Document all customer interactions and next steps
Partner with Business Development on:
Large, complex, or strategic opportunities
Assigned accounts requiring BD ownership
Collaborate with marketing, operations, and scientific teams to support deal execution
Utilize internal tools and AI platforms to enhance efficiency
Achieve and exceed KPIs related to:
Revenue closed (primary metric)
Pipeline generated
Conversion rates (lead → opportunity → closed won)
Speed-to-lead and sales cycle time
Maintain accurate reporting and forecasting within CRM systems
Minimum Requirements:
Bachelor’s degree in Life Sciences, Biology, or related field
2–5+ years of experience in inside sales, business development, or commercial roles within CRO, biotech, or life sciences
Working knowledge of pre-clinical research and biomarker applications, including:
Immunohistochemistry (IHC)
Flow cytometry
Genomics and proteomics
Strong commercial acumen with the ability to manage and close deals independently
Ability to engage scientific stakeholders and translate technical discussions into business opportunities
Excellent communication, negotiation, and presentation skills
Highly organized with strong attention to detail
Self-motivated and comfortable working in a fast-paced environment
Preferred Requirements:
Experience managing opportunities through the full sales cycle preferred
Familiarity with translational research workflows is a plus
Proficiency with CRM systems (Salesforce preferred)
The salary range for this position is $75,000-85,000. This salary (or salary range) is merely an estimate and may vary based on an applicant’s skills and prior relevant experience.
Crown Bioscience is committed to a diverse and inclusive workplace. Crown Bioscience is an equal opportunity employer and does not discriminate based on race, national origin, gender, gender identity, sexual orientation, protected veteran status, disability, age, or other legally protected status.

Crown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) dedicated to accelerating drug discovery and development in oncology and immuno-oncology. We partner with biotech and pharmaceutical companies to provide innovative, tailored solutions spanning preclinical research, translational platforms, and clinical trial support.
With the world’s largest commercially available patient-derived xenograft (PDX) collection and approximately 1,000 tumor organoid models powered by Hubrecht Organoid Technology, we offer unparalleled insights across 35 cancer indications.
Our expertise spans in vivo, in vitro, ex vivo, and in silico methods, complemented by advanced laboratory services that span the entire drug development continuum. Additionally, our extensive biobank of liquid and human biospecimens, complete with clinical histories, enhances oncology research capabilities.
Operating from 11 state-of-the-art facilities across the US, Europe, and APAC, our laboratories meet the highest industry standards, including accreditation by the College of American Pathologists (CAP) and the International Organization for Standardization (ISO).
To learn more, visit www.crownbio.com.